Can We Really Prevent Suicide? by Schwartz Laufer, Maya et al.
MOOD DISORDERS (SM STRAKOWSKI, SECTION EDITOR)
Can We Really Prevent Suicide?
Maya Schwartz-Lifshitz & Gil Zalsman & Lucas Giner &
Maria A. Oquendo
Published online: 21 September 2012
# Springer Science+Business Media, LLC 2012
Abstract Every year, suicide is among the top 20 leading
causes of death globally for all ages. Unfortunately, suicide
is difficult to prevent, in large part because the prevalence of
risk factors is high among the general population. In this
review, clinical and psychological risk factors are examined
and methods for suicide prevention are discussed. Preven-
tion strategies found to be effective in suicide prevention
include means restriction, responsible media coverage, and
general public education, as well identification methods
such as screening, gatekeeper training, and primary care
physician education. Although the treatment for preventing
suicide is difficult, follow-up that includes pharmacothera-
py, psychotherapy, or both may be useful. However, pre-
vention methods cannot be restricted to the individual.
Community, social, and policy interventions will also be
essential.
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Introduction
The World Health Organization (WHO) defines suicide as
the act of killing oneself. The act must be deliberately
initiated and performed by the person concerned in the full
knowledge, or expectation, of its fatal outcome [1]. Suicide
is among the top 20 leading causes of death globally for all
ages and every year, nearly one million people die from
suicide. Worldwide, suicide ranks among the three leading
causes of death among those aged 15–44 years, and the
second leading cause of death in the 10–24 years age group
[2]. The global suicide rate is 16 suicides per 100,000
inhabitants: more specifically 18 suicides per 100,000 males
and 11 suicides per 100,000 females [2]. Clinical studies
have demonstrated that in most countries, suicide predomi-
nates in males, although there are important exceptions such
as China. Of note, the suicide rate increases with age, although
suicide rates among young people have been increasing to
such an extent that they are now the group at highest risk in a
third of countries, in both developed and developing
countries. As well, there are marked differences in suicide
rates between some ethnic groups and individual countries,
and also within different regions of one country.
A suicide attempt is a self-inflicted, potentially injurious
behavior with a nonfatal outcome for which there is evidence
(either explicit or implicit) of intent to die [3, 4]. It is estimated
that for every suicide, there are 50 suicide attempts, and thus
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attempts are a source of significant morbidity. Moreover, the
Youth Risk Behavior Surveillance study suggests that as many
as 7 % of adolescents in the United States acknowledge
having attempted suicide.
Identifying individuals at imminent risk for suicidal behav-
ior is a major challenge for clinicians. In general, suicide is
hard to predict because the prevalence of risk factors is high
among the population, while suicide is rare. Indeed, only a
minority of those with risk factors will commit suicide. Fur-
thermore, some of the risk factors are not specific and of those
who die by suicide, some are not in any risk group. Nonethe-
less, up to 90 % of the people who commit suicide, and a
similar rate of those who attempt suicide, suffer from a psy-
chiatric disorder (affective illnesses, drugs/alcohol abuse, psy-
chosis or personality disorders [5–8]). On the other hand,
among psychiatric populations, suicidal behavior is not rare
and the rate of attempts among psychiatric patients ranges
between 15–50 % [9].
Despite the challenges in identifying those at risk for
suicidal behavior, opportunities for prevention do exist. In
many cases, suicidal persons have been in contact with
general practitioners in the month prior to their death
[10–12], although, up to 80 % of them were not treated for
their psychiatric condition at that time of death [13–15].
This contact with the medical profession may afford an
opportunity for intervention.
Risk Factors
Diagnostic Risk Factors
Depressive Disorders
More than half of all clinically depressed persons have
suicidal ideation and Major Depression Disorder and Bipolar
Disorders are the psychiatric disorders most often associated
with suicide [16]. Some symptoms of depression have been
identified as particularly important in risk for suicidal behav-
ior: hopelessness, feelings of guilt, loss of interest, insomnia,
and low self esteem [17•]. Effective prevention and treatment
of mood disorders might reduce the number of suicide
attempts, given that most depressed patients at the time of
suicide attempt are inadequately treated [16]. Thus, treating
suicidal depressed patients actively and intensively might
offer an effective way of preventing suicidal behavior.
Bipolar Disorders
Suicidal ideation is highly prevalent in patients with bipolar
disorders, and it is estimated that as many as half of those
who have bipolar disorder attempt suicide at least once. The
suicide rate among these patients is more than 20 times
higher than that of the general population [5] and the risk
of suicide is highest early in the course of Bipolar Disorder,
particularly in the first year of the illness. The presence of
depressive and dysphoric–irritable states in Bipolar Disorder
is reported to be a risk factor for suicide [8]. Other work
suggests that hopelessness predicts suicidal behavior during
the depressive phase, and that severity of depression predicts
suicide attempts during mixed episodes [17•]. Therefore,
aggressive and effective management of depressive
phases is essential, as depressive phases are high risk
periods for suicidal behavior.
Anxiety Disorders
Anxiety disorders are associated with lifetime suicidal ide-
ation and suicide attempts, especially in adolescents and in
young adults [18]. Among anxiety disorders, Panic Disorder
and Post Traumatic Stress Disorder (PTSD) have the stron-
gest associations with suicidal behavior. However, whether
anxiety disorders alone or whether presence of anxiety in the
context of a mood disorder increases risk for suicidal be-
havior remains an open question. For example, a link be-
tween suicidality and panic/anxiety disorders has been
reported [19, 20] at times, independently from the presence
of comorbid depression, substance abuse and personality
disorders [3]. However, Placidi et al. [21] found that comor-
bid panic disorders in patients with major depression did not
increase the risk for lifetime suicide attempts. Moreover,
non-attempters scored higher in the anxiety items in the
Hamilton depression scale. It may be that anxiety symp-
toms, like fear of disability or death, serves as a protective
factor for suicide. In terms of PTSD, a review by Panagioti
et al. [22] found a relationship between PTSD and suicidal
thoughts and behaviors, irrespective of the type of trauma
experienced. In many PTSD studies, suicidality is associated
with comorbid depression and substance abuse [17•]. There-
fore, the increased proportion of suicide attempters among
persons with a PTSD diagnosis may be due to the comorbid
depression and not to PTSD itself. Given that anxiety is highly
comorbid with other mental disorders, especially mood dis-
orders and substance abuse, the role of severe anxiety as a
marker of acute suicide risk requires further study.
Alcohol and Other Substance Abuse
Substance misuse disorders increase the risk of suicidal behav-
iors, alcohol being the most significant risk factor among the
substances. Alcohol misuse and abuse predispose to impulsiv-
ity, aggression, depression, hopelessness, and other negative
factors that increase the risk for suicidal behavior. Individuals
who commit suicide and suffer from alcohol and other sub-
stance abuse disorders are often younger males, divorced or
separated. They often suffer from recent adverse life events,
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and are likely to be intoxicated at the time of the suicide [23]. In
terms of suicide attempts, the presence of alcohol misuse dis-
orders is also a significant risk factor. Moreover, when co-
morbid with affective disorders, presence of alcohol misuse
disorders increases risk of suicide attempts by more than two
fold [24].
Schizophrenia and Other Psychoses
Suicide attempt is prevalent in patients with schizophrenia
and other psychotic disorders [25] and occurs in as many as
23–31 % of those afflicted depending on the global region.
Meanwhile, the lifetime suicide risk for people with schizo-
phrenia is estimated to be about 5 % [26]. The risk factors
for suicide in schizophrenia are past and present suicidal
behavior, past depressive episodes, drug abuse or depen-
dence and more frequent psychiatric admissions [27]. Of
note, other risk factors, such as fear of mental disintegration,
agitation or restlessness, and poor adherence to treatment,
all increase risk for suicidal behavior and may be more
specific to schizophrenia [28]. The great majority of suicides
in schizophrenia occur in the active phase of the disorder, in
the context of depressive symptoms [17•]. That suicides are
most common early in the course of the illness suggests
that prevention and treatment should focus on the early stages
of disease.
Personality Disorders
Personality disorders have been shown to be related to
suicidal and self-injurious behavior, both among the general
and the psychiatric population [29]. Moreover, many suicide
attempters meet criteria for a personality disorder [30, 31].
Although borderline personality disorder is the only person-
ality disorder that lists suicidal behavior as a criterion, other
personality disorders, such as antisocial and other Cluster B
personality disorders [32] also increase risk of suicidal be-
havior. Personality disorders are often accompanied by im-
pulsivity, aggression, alcohol and substance abuse, as well
as major depressive episodes, all of which are known risk
factors for suicide in their own right.
Other Risk Factors
Aggression, Impulsivity, and Hostility
Levels of impulsivity, hostility and aggression are higher in
suicide attempters compared to non-attempters among peo-
ple who suffer from major depression [33]. Among bipolar
patients, past suicide attempters report more lifetime aggres-
sion than non-attempters [34]. Aggression is an important
variable in the prediction of suicidal behavior as well [16].
Of note, although impulsivity contributes to the future risk
of suicidal behavior [35], it appears to lower the lethality of
the suicidal act, since it detrimentally affects one’s planning
ability. In support of this, older suicides are reported to have
lower levels of impulsivity and aggression compared to
young suicides.
Hopelessness
Hopelessness was found to be associated with future suicide
attempts both in the short and long term [19, 36–38]. Fur-
thermore, in mood disorders, it predicts suicidal behavior as
part of a pessimism factor, which also includes measures of
subjective depression, suicidal ideation and reasons for
living [37]. Whether hopelessness as a trait rather than a
symptom of depression is of import remains an open
question.
Heredity
Suicidal behavior is highly familial [3, 39, 40] and a family
history of suicidal behavior is associated with suicide
attempts and suicide all through the life cycle and across
psychiatric diagnoses [41]. This transmission is independent
of the transmission of psychiatric disorders [42, 43]. Instead,
the familiality of suicidal behavior appears to be mediated
by the transmission of a tendency to impulsive aggression,
traits that leads the patient to a higher tendency to act upon
suicidal thoughts [44, 45].
Childhood Trauma
Childhood trauma is also a risk factor for suicide attempt.
Moreover, the amount of trauma experienced by the child,
correlates with younger age at the first suicide attempt and
an increased number of suicide attempts [46].
Past Attempts and Ideation
A suicide attempt in the past is a major risk factor for suicide
[3, 16] as well as future suicide attempt, especially among
people suffering from affective disorders [46–52]. Repeated
suicide attempts increase the risk of future suicidal behavior,
as was demonstrated by Leon et al. [53]. Oquendo et al. [54]
found a 50 % increase in the risk of future suicidal behavior
for each previous attempt made by the individual. The
evidence for suicidal ideation by itself as a risk factor for
suicide acts is more nuanced. In a prospective study [37],
suicidal ideation alone did not predict future suicide
attempts or completion. In contrast, other studies have iden-
tified suicidal ideation as a precursor of attempted and
completed suicide among patients with mood disorders
[55–58] and as correlated with greater risk of future suicide
attempts (as part of a pessimism factor) among bipolar
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patients presenting with a major depressive episode [59].
Not surprisingly, suicide attempters also are more likely to
endorse suicidal ideation during subsequent acute phases or
hospitalizations [34, 60]. Therefore, it is reasonable to view
suicide ideation as a risk factor for suicide, either as an
independent risk factor, or as part of a factor integrating
measures of subjective depression, reasons for living, and
hopelessness [16].
Preventive Measures
Since a variety of factors are involved in the suicidal act,
multimodal approaches coveringmultiple levels of intervention
and activities will be essential to any preventive strategy. Thus
far, prevention strategies found to be effective in suicide pre-
vention include means restriction, responsible media coverage
and general public education, as well identification methods
such as screening, gatekeeper training, and primary care phy-
sician education.
Means Restriction
Suicide attempts using highly lethal means, such as firearms
in US men, or pesticides in rural China, India, and Sri
Lanka, result in high rates of death [10]. The most frequent
means of suicide in Europe is hanging [61] and in North
America, firearms [62]. Suicide methods are necessarily
influenced by their accessibility. In many countries, restriction
of access to commonmeans of suicide has led to lower overall
suicide rates [63]. For example, increasing firearm control in
the US and Canada [64–66], detoxification of domestic and
motor vehicle gas [67, 68], restrictions on use of toxic pesti-
cides in rural areas [10], and physical barriers at jumping sites
[69, 70] are reported to be of utility in reducing suicides. In
addition, reducing access to ligature and ligature points in
prisons and hospitals has reduced instances of hanging [71]
while introducing safer antidepressant, selling smaller pack-
ages of analgesics or individually wrapped analgesics, and
restricting of the sale of barbiturates has reduced suicides by
overdose [72]. Thus, public policy to reduce access to means
for suicide has an important role in prevention.
Responsible Media Coverage
Responsible media coverage is key to suicide prevention by
providing the public information on mental disorders and
their treatment, and ways of identifying persons at risk.
Glorification and dramatization of a suicidal act can be
followed by a series of suicides, especially among adoles-
cents ("contagion"), thus it is important to stress that the
person who lost his life to suicide is ill and not in any way a
hero. Programs to educate the media about coverage of
suicides are available through foundations (American Foun-
dation for Suicide Prevention) and emphasize the impor-
tance of reporting suicide as a public health issue, in a
non-sensational way. Media coverage should emphasize
the treatable causes of suicide, such as substance abuse
and mental disorders. Discussing the available treatment
options for these problems and the types of healthcare
providers who can treat them may encourage help seeking
behavior by those contemplating suicide. As well, because
many individuals considering suicide exhibit warning signs,
educating the public about such signs can help relatives
identify and respond quickly and efficiently to the person
in need. In addition, it is essential that media coverage not
link suicide only to external events, like divorce, a recent job
loss or school failure, dramatic as they may be. Instead,
emphasizing the frequency of psychiatric conditions among
those who die by suicide and providing education about
possible interventions can be helpful to communities exposed
to highly visible suicides. Of note, media reports covering
specific suicide methods were found to increase suicidal behav-
iors in the community in some studies [73, 74]. Therefore, it is
advisable to avoid inclusion of specific details such as the
location or method of death in news reports.
Identification Methods
Before suicidal behavior can be prevented, those at risk need
to be identified. Since not all potential suicide attempters are
in close contact with a mental health professional, those
around them (e.g., friends, family, school staff, military
commanders and primary care givers) should be equipped
with tools to properly identify risk and make a timely
referral.
General Public Education
Public education campaigns are aimed mostly at improving
suicide risk recognition and help-seeking behavior and re-
ducing the stigma of mental illness [75••]. Some campaigns
address suicidal behavior directly, as was done in the United
States Air Force suicide prevention program [76], while
others target depressive disorders [77–79]. However, Mann
et al. [10] found no detectable effects of public awareness
campaigns, neither on reducing the rate of suicidal acts, or
on increasing treatment seeking or antidepressant use. Fur-
ther, a review by Dumensil and Verger [80•] examined 15
public education campaigns in eight countries and found
that these programs improved the general public’s knowl-
edge of suicide and depression and contributed at least
moderately to better social acceptance of people with de-
pression and other mental illnesses. Unfortunately, no study
clearly demonstrates increased care seeking or decreased
suicidal behavior after such campaigns. However, it still
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may be the case that awareness campaigns have an effect
when combined with other measures in a multilevel and
multifaceted intervention program [76, 81]. This was demon-
strated in the Nuremberg Alliance against Depression (NAD),
a two year intervention program that included four levels: (1)
Training of general practitioners and support through different
methods; (2) A public relations campaign informing about
depression, (3) Cooperation with community facilitators
(teachers, priests, local media, etc.), and (4) Support for self-
help activities as well as for high-risk groups. The program was
found to be effective in lowering the rate of suicidal acts by
approximately 20 % (suicide attempts and completed suicide)
[81]. The program demonstrated the additive and synergistic
effect of combining all four intervention levels simultaneously.
The European Alliance against Depression (EAAD), an EU-
funded network of partners from 17 countries adopted this
multifaceted intervention approach, and is currently conducting
a test in Hungary, Portugal, Germany and Ireland. Results of
this initiative have yet to be released.
Primary Care Physicians Training
On average, 77 % of the people who commit suicide were in
contact with a primary care physician in the year before their
death, and about 45 % came in contact with a primary care
provider in the month prior to their death [11]. However,
under-recognition and under-treatment of psychiatric disorders
in primary care setting presents a challenge for identifying
those at risk and while mental disorders are present in most
cases of suicide, most suicides are untreated at the time of
death [13]. Fortunately, education of primary care physicians
in recognition and treatment of depression may be an efficient
means for lowering suicide rates [10, 63, 82]. Indeed, studies
that examined programs for primary care physician training
found a rise in the antidepressant prescription rates and a
decline in the suicide rate after the program [81, 83].
Gatekeeper Training
Gatekeepers are figures with the potential to influence the
suicidal person on a temporary or ongoing basis (e.g., family
members, friends, authority figures- a parent, teacher or a
military commander, educators, social workers, nursing
home staff and volunteers) and can serve as a support
resource. The training of gatekeepers focuses on recognizing
suicidal thinking and behavior and helping people at risk to
access appropriate services [10]. The key elements of the
training include: learning about depression and suicide, train-
ing in practical elements (e.g., how to talk about suicide,
detect suicide risk, handle an acute suicidal crisis etc.), in-
struction onwhat to do if treatment needs are encountered, and
strategies for recognizing populations vulnerable to suicide
[75••]. Success of gatekeeper training in lowering suicide rates
has been reported in military and school programs [76, 84]. In
a group-based randomized trial conducted by Wyman et al.
[85], Question, Persuade, Refer (QPR) training of a random
sample of school staff increased their knowledge of youth risk
factors for suicide. The program also increased the staff's
commitment to assisting students in receiving help before
engaging in potentially lethal self-harm behaviors. The gate-
keeper training, however, did not overcome the students’
reluctance to seek assistance from adults, underscoring the
need to improve the communication between school staff and
difficult-to-reach students.
Screening
Screening aims to identify at-risk individuals and direct them to
treatment [10]. The Columbia Suicide Screen® (CSS) question-
naire is a brief, self-administered set of questions intended to
identify high school students at risk of suicide. In a study that
examined the efficiency of the CSS in identifying high school
students at risk of suicide [86], the algorithm that gave both the
highest specificity and the best balance between sensitivity and
specificity (0.75 and 0.83, respectively) screened for suicidal
ideation or previous attempt and self reported unhappiness,
withdrawal, or irritability and anxiety. A review of studies of
depression screening in adults in primary health care settings
performed for the US Preventive Services Task Force [87]
found higher detection and diagnosis rates of depression
through the use of screening tools. It was also found that brief
questionnaires, such as the PHQ-2 which ask two questions: (1)
“Over the past 2 weeks, have you felt down, depressed or
hopeless?” and (2) “Over the past 2 weeks, have you felt little
interest or pleasure in doing things?” appeared to perform as
well as lengthier questionnaires (e.g., the Zung Self-Depression
Scale and the Beck Depression Inventory). Indeed, screening
was associated with a 13 % reduction in the relative risk of
remaining depressed and a 9–percentage point absolute reduc-
tion in the proportion of patients with persistent depression.
Moreover, a review of evidence on screening for suicide risk
[88], suggests that focusing on screening high-risk groups
(depressed patients, substance abusers) in primary care settings
may decrease suicide rates. Since depression is common, af-
fecting about 121 million people worldwide [89], and the
burden of this disease is significant -depression is the second
cause of Disability Adjusted Life Years in the age category 15–
44 years for both sexes combined and it is expected that by the
year 2020, depression will reach that status for all age groups-
there may be room to consider depression screening in primary
care settings, much like screening for hypertension or diabetes.
Treatment
Suicide is complex involving psychological, social, biological,
cultural and environmental elements. Therefore, a combination
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of treatment and support strategies – psychotherapy, pharma-
cotherapy, follow up treatment and support for those who lost a
loved one to suicide, may provide effective measures against
suicidal behavior.
Psychotherapy
Several evidence based psychotherapies have been shown to
be of utility in the treatment of those at risk for suicidal
behavior. This is the case not only because psychotherapy,
with or without medication, can reduce depressive symptoms,
but because it can specifically target suicidal ideation and
suicide attempts [10]. For example, Cognitive Behavioral Ther-
apy (CBT) is an evidence-based method for reducing suicide
attempt rates and improving adherence to treatment. This treat-
ment has been shown to be effective when directly focused on
reducing aspects of suicidal behavior [90–93]. Similarly, given
that suicidal people often lack psychosocial resources, increas-
ing problem-solving capacity through Problem Solving Thera-
py may reduce the burden of unsolved problems, and as a
result, reduce hopelessness, depressive symptoms and suicidal
thoughts [94, 95]. Interpersonal therapy, which identifies and
resolves interpersonal difficulties which cause or exacerbate
psychological distress has also been found to decrease suicidal
ideation [94]. As well, Dialectical Behavioral Therapy (DBT)
has been shown to reduce self-injury and suicidal behavior in
individuals with borderline personality disorder [95, 96].
Pharmacotherapy
Given the importance of psychiatric illness as a contributor
to suicide risk, providing suitable, robust pharmacotherapy
for psychiatric disorders is critical to suicide prevention.
Antidepressants
Depression is the psychiatric condition most often associated
with suicidal behavior. The lifetime suicide risk rate among
depressed (unipolar and bipolar) patients is 10–15 % [74].
Antidepressants are the treatment of choice for the relief of
depressive symptoms and suicidal ideation, which often
accompanies depression [97, 98]. Antidepressants significantly
reduce the risk of suicidal ideation and suicidal behavior in
patients with major depression [3]. Moreover, higher prescrip-
tion rates of antidepressants correlate with a decrease in suicide
rates [99–101]. Due to their relative safety in cases of overdose,
and relatively mild side effects, SSRIs are considered first line
therapy in primary care settings [102]. However, children,
adolescents and young adults under the age of 24 may para-
doxically experience an induction or worsening of suicidal
ideation or behavior. A systematic review of randomized con-
trol trials aimed at establishing the association between SSRIs
and suicide attempts [103] found a more than twofold increase
in the rate of suicide attempts in patients receiving SSRIs
compared with placebo or therapeutic interventions other than
tricyclic antidepressants (TCA). However, there was no differ-
ence in suicide deaths between SSRIs and placebo. Similarly, a
meta-analysis by Gunnel at al. [104] found weak evidence for
increased risk of non-fatal self harm in patients taking SSRI's
compared with placebo, but no evidence for increased suicide
risk. Possible explanations for these findings are that SSRIs can
cause agitation, anxiety, insomnia and akathisia at the initiation
of treatment, all of which may increase suicide risk among
young depressed patients. Potential solutions include closer
observation of patients with mild illness who are being
treated in the community by general practitioners, family
and close friends.
Why younger individuals are at risk for worsening sui-
cidal ideation upon exposure to antidepressants is not
known but may be due to the complex nature of depression
among children and adolescents, which can mask a bipolar
disorder or personality traits. The Food and Drug Adminis-
tration (FDA) has issued a “black box” warning on the use
of antidepressants among this age group [105], and it is
recommended that children and adolescents taking this class
of medication be under close monitoring for side effects.
Clearly, the clinician must consider the risks and benefits
entailed in the use of antidepressants, especially SSRIs, in
the treatment of depression in patients under the age of 24.
Mood Stabilizers
Lithium is reported to reduce both attempted and completed
suicides in major mood disorders, such as unipolar depres-
sion and bipolar patients with long-term lithium treatment
[106, 107]. A meta analysis by Baldessarini et al. [106]
found that risk of completed and attempted suicide were
lower by approximately 80 %, during treatment of bipolar
and other major affective disorder patients with lithium.
Long term lithium treatment also may reduce the lethality
of suicidal acts, perhaps by limiting impulsivity and aggres-
siveness. Nonetheless, a cause for concern is lithium’s lim-
ited therapeutic index or margin of safety, such that lethal
outcomes can occur in the setting of suicide attempt by
overdose. Interestingly, the fatality risk of lithium overdoses
is moderate, much like that of modern antidepressants and
second-generation antipsychotics [108]. That notwithstand-
ing, close patient monitoring and education about adherence
to treatment is important since abrupt discontinuation of the
treatment with mood stabilizers can cause a rebound in-
crease in suicidal ideation [109, 110].
Antipsychotics
Clozapine has been shown to have an anti-suicidal effect in
schizophrenia [111] compared to both placebo and other
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second generation antipsychotics and is the only FDA
approved drug for treatment of suicidal behavior. Of
note, a study by Spivac et al. [112] suggests that this
effect is due, in part, to a reduction in impulsiveness
and aggression. However, because suicidal ideation and
behavior in schizophrenia can emerge as part of an
acute psychosis, severe anxiety, agitation, or depression,
sedating antipsychotics or antidepressants respectively,
may be useful. Given that some atypical antipsychotics
have antidepressant effects [113, 114] they may also be
of utility in schizophrenia accompanied by suicide risk.
Electroconvulsive Therapy
There is extensive evidence that ECT is an effective treat-
ment for acute suicidality among severely depressed patients
[115]. This treatment can also reduce the risk of subsequent
suicidal behavior. Thus, although in most countries the use
of Electroconvulsive therapy (ECT) is reserved for major
depressive episodes that have been shown to be “treatment
resistant” to adequate trials of two or more pharmacothera-
pies, presence of acute suicide risk should clearly be an
indication for ECT regardless of the treatment history.
Follow-Up After Suicide Attempt
Recurrent suicidal behavior places a great burden on patients
and their families, as well as on the health care system as a
whole. Since previous suicide attempts are a major risk factor
in predicting further suicidal behavior and suicide [116, 117],
adequate follow-up care after a suicide attempt for patients
and their families is crucial in prevention.A fewmethods have
been found to be efficient. The Green Card Study [118] is an
initiative aimed at increasing compliance among Deliberate
Self Harm patients after discharge. The initiative offered
patients after deliberate self harm a “lifeline”- easy access to
on call psychiatrists, and encouraged them to make contact
should difficulties arise. A doctor was available at all times,
and the intervention included crisis admission if necessary.
This kind of initiative showed a significant reduction of de-
liberate self-harm. Furthermore, it did not require a significant
amount of resources. Carter et al. [119] found that ongoing
contact after hospital discharge via postcards lowered the
number of repeat suicide attempts by nearly 50%. This model
emphasized social connectedness, respect for the patient and
high quality medical and psychiatric management after hos-
pital discharge. The Norwegian initiative [120] which provid-
ed follow-up care after suicide attempts via a chain-of-care
network also is reported to reduce suicide rates. Involvement
of the family in aftercare following a suicide attempt is critical
since theymay constitute the main support system. The family
may also serve as after care monitors for treatment adherence
and detection of any signs of suicidality [121].
Conclusions
Suicide prevention requires strategies that encompass work
at the individual, systems and community level. Policy
directed at means restriction and public awareness campaigns
can be used in combination with strategies directed at the
individual, including identification, proper diagnosis and
effective treatments. Given the complexity of identifying
and managing suicide risk, a combination of interventions
at several levels will be required in order to implement an
efficacious, comprehensive prevention program.
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